Back to results
US 2014/0230812 A1Published application
Compositions comprising salbutamol sulphate
AssigneeMexichem Amanco Holdings S.A. De C.V.
InventorsStuart Corr, Timothy James Noakes
Life of this patent
Estimating the term…
Abstract
A pharmaceutical composition is described that is suitable for delivery from a pressurised container. The composition is free of polar excipients and comprises: (a) a propellant component that consists essentially of 1,1-difluoroethane (R-152a); (b) a surfactant component that comprises oleic acid; and (c) a drug component that consists of salbutamol sulphate. The pharmaceutical composition can be delivered using a metered dose inhaler (MDI).
Claims14
A pharmaceutical composition consisting essentially of:
- (a) 1,1-difluoroethane (R-152a),
- (b) oleic acid;
- and
- (c) salbutamol sulphate.
1 more element
2-6. (canceled)
Dependencies are inferred from the claim text.